Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6631 to 6645 of 7680 results

  1. Impedance-controlled endometrial ablation for menorrhagia (IPG104)

    This guidance has been updated and replaced by NICE guideline CG44.

    Interventional procedures guidance
    Published
    15 December 2004

  2. Retifanlimab for treating anal canal squamous cell carcinoma after platinum-based chemotherapy [ID3815]

    Discontinued [GID-TA10698]

    Technology appraisal guidance
    Discontinued

  3. Maternal health: promoting maternal health through community based strategies

    Discontinued [GID-QS10016]

    Quality standard
    Discontinued

  4. Mastocytosis (systemic) - masitinib [ID781]

    Discontinued [GID-TA10019]

    Technology appraisal guidance
    Discontinued

  5. Management and organisational approaches to safe staffing

    Discontinued [GID-SGWAVE0761]

    Safe staffing guideline
    Discontinued

  6. Eflornithine with sulindac for treating familial adenomatous polyposis [ID1543]

    Discontinued [GID-TA10536]

    Technology appraisal guidance
    Discontinued

  7. Durvalumab with tremelimumab for untreated PD-L1-positive urothelial bladder cancer [ID1335]

    Discontinued [GID-TA10315]

    Technology appraisal guidance
    Discontinued

  8. Belatacept for the prevention of organ rejection in kidney transplantation [ID87]

    Discontinued [GID-TAG239]

    Technology appraisal guidance
    Discontinued

  9. Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]

    In development [GID-TA10555] Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Vorapaxar for reducing atherothrombotic events after a myocardial infarction or in peripheral vascular disease [ID616]

    Discontinued [GID-TAG493]

    Technology appraisal guidance
    Discontinued

  11. Rivogenlecleucel for treating haematological cancers in children and young people undergoing haploidentical haematopoietic stem cell transplant [ID1601]

    In development [GID-TA10467] Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. Community nursing care settings

    Discontinued [GID-SGWAVE0700]

    Safe staffing guideline
    Discontinued

  13. Diagnostic services

    Discontinued [GID-CGWAVE0773]

    NICE guideline
    Discontinued

  14. Vemurafenib for treating resected BRAF V600 mutation-positive melanoma [ID1250]

    Discontinued [GID-TA10213]

    Technology appraisal guidance
    Discontinued

  15. Apalutamide for treating non-metastatic, hormone-relapsed prostate cancer [ID1174]

    Discontinued [GID-TA10377]

    Technology appraisal guidance
    Discontinued